Pfizer had an `18% run-up between mid-November and the end of January and it now is likely to do relatively little additionally on the upside the next few months while it consolidates those gains. I do expect it to move higher though after that consolidation and I currently have a one-year target price of $32 for the stock.
Going back at least as far as 1982, PFE has had a minimum trading range on a closing basis of at least 23.7% as measured from the low close of the year to the high close of the year. In 28 of the 31 years, the range was at least 25% but in no case was it lower than the 23.7% seen in 1988. The 2013 low close has been the $25.85 seen on Jan. 3 and if that holds, there should be at least one 2013 close in the $32 area or higher. Many on this board scoff at this sort of thing but it's pretty tough to argue with at least 31 consecutive years without exception where this has worked. And for all I know, it may have worked for 50 or more consecutive years; I'm unable to get daily prices going back further than 1982.